Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ana Oaknin | Researchclopedia

Back to researchers

Ana Oaknin

Hebron University ORCID

710

Works

35,571

Citations

71

h-index

209

i10-index

Research Topics

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Endometrial and Cervical Cancer Treatments

Affiliations

Université Claude Bernard Lyon 12014–2014

AstraZeneca (United Kingdom)2019–2019

Creighton University2014–2014

Universitat de Vic - Universitat Central de Catalunya2023–2023

Roche (Switzerland)2019–2019

Top Works

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Kathleen N. Moore,Nicoletta Colombo,et al.

20182,766 citations

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

Cervical cancer

Paul A. Cohen,A. Jhingran,et al.

20192,380 citations

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh,James Carmichael,et al.

20102,279 citations

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman,Amit M. Oza,et al.

20171,678 citations

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

Éric Pujade-Lauraine,Felix Hilpert,et al.

20141,598 citations

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari,Michael W. Sill,et al.

20141,486 citations

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Elizabeth M. Swisher,Kevin Lin,et al.

20161,191 citations

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman,Gini F. Fleming,et al.

2019913 citations

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Funda Meric‐Bernstam,Vicky Makker,et al.

2023815 citations